4DMedical is trading 10.53% up now at A$4.20, primarily driven by global risk-on sentiment after a strong broader-market recovery on September 17, 2026.
- Lower yields and easing oil prices supported the recovery.
- 4DMedical presented its lung-imaging platform at the Life Sciences Virtual Investor Forum, highlighting clinical progress, reimbursement, cash resources and international expansion plans.
- Coverage did not explicitly link the presentation to the move; the S&P 500 rose 1.14% and Nasdaq 1.66%.